An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt’s lymphoma: results of United Kingdom Lymphoma Group LY06 study-Reference-Cited by-同舟云学术

An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt’s lymphoma: results of United Kingdom Lymphoma Group LY06 study

Published:2002-08 Issue:8 Volume:13 Page:1264-1274
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Mead G.M.,Sydes M.R.,Walewski J.,Grigg A.,Hatton C.S.,Norbert P.,Guarnaccia C.,Lewis M.S.,McKendrick J.,Stenning S.P.,Wright D.

Publisher

Elsevier BV

Link

http://academic.oup.com/annonc/article-pdf/13/8/1264/334445/mdf253.pdf

Reference33 articles.

1. A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group;Harris;Blood,1994

2. The World Health Organization classification of neoplastic diseases of the hematopietic and lymphoid tissues;Harris;Ann Oncol,1999

3. What is Burkitt’s lymphoma and when is it endemic?;Wright;Blood,1999

4. The Non-Hodgkin’s Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma;Blood,1997

5. Mature B-cell lymphoma/leukemia in children and adolescents: intergroup pathologist consensus with the revised European–American lymphoma classification;Lones;Ann Oncol,2000

Cited by 288 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Data on Outcome of Burkitt Lymphoma and Burkitt Leukemia Treated According to the GMALL B-ALL/NHL 2002 Protocol: A Tertiary Center Experience;Clinical Lymphoma Myeloma and Leukemia;2025-07

2. Survival analysis in adult Burkitt Lymphoma in Colombia according to HIV status;Cancer Epidemiology;2025-06

3. CAR T- cell therapy provides an opportunity for further consolidation treatment for relapsed or refractory adult Burkitt lymphoma patients;Frontiers in Oncology;2025-05-23

4. Rituximab for children with EBV-positive Burkitt lymphoma in East Africa;Blood Advances;2025-05-14

5. Real-world efficacy and toxicity of the LMBA02 protocol for Burkitt lymphoma in Morocco;Bulletin du Cancer;2025-04